Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Ramanathan

Showing results (191-200 of 302) with videos related to

Pageof 31
Sort By:
Cancer Chemotherapy and Pharmacology|March 28, 2012
Population pharmacokinetic analysis of 17-dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG) in adult patients with solid tumorsAbdulateef O Aregbe, Eric A Sherer, Merrill J Egorin, et al.
Cancer Chemotherapy and Pharmacology|August 24, 2004
Pharmacokinetic studies of 9-nitrocamptothecin on intermittent and continuous schedules of administration in patients with solid tumorsLaura L Jung, Ramesh K Ramanathan, Merrill J Egorin, et al.
Clinical Pharmacology and Therapeutics|August 14, 2009
Pharmacokinetic study of pegylated liposomal CKD-602 (S-CKD602) in patients with advanced malignanciesW C Zamboni, S Strychor, L Maruca, et al.
American Journal of Clinical Oncology|October 4, 2005
A phase I/II study of trimetrexate and capecitabine in patients with advanced refractory colorectal cancerKhalid Matin, Samuel A Jacobs, Thomas Richards, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 29, 2005
Chemotherapy permits resection of metastatic colorectal cancer: experience from Intergroup N9741T Delaunoit, S R Alberts, D J Sargent, et al.
Cancer Immunology, Immunotherapy : CII|September 17, 2004
Phase I study of a MUC1 vaccine composed of different doses of MUC1 peptide with SB-AS2 adjuvant in resected and locally advanced pancreatic cancerRamesh K Ramanathan, Kenneth M Lee, John McKolanis, et al.
Cancer Chemotherapy and Pharmacology|January 1, 2013
A phase I study of liposomal-encapsulated docetaxel (LE-DT) in patients with advanced solid tumor malignanciesJohn F Deeken, Rebecca Slack, Glen J Weiss, et al.
Cancer|January 20, 2011
Patient willingness to undergo pharmacodynamic and pharmacokinetic tests in early phase oncology trialsRaoul Tibes, Barbara F Piper, Jessica A Smith, et al.
Journal of Pharmaceutical Sciences|January 8, 2011
Validation of 96-well equilibrium dialysis with non-radiolabeled drug for definitive measurement of protein binding and application to clinical development of highly-bound drugsMaciej J Zamek-Gliszczynski, Kenneth J Ruterbories, Rose T Ajamie, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 13, 2008
Five-year data and prognostic factor analysis of oxaliplatin and irinotecan combinations for advanced colorectal cancer: N9741Hanna K Sanoff, Daniel J Sargent, Megan E Campbell, et al.
Pageof 31

Showing results (191-200 of 302) with videos related to

Sort By:
Pageof 31
Cancer Chemotherapy and Pharmacology|March 28, 2012
Population pharmacokinetic analysis of 17-dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG) in adult patients with solid tumorsAbdulateef O Aregbe, Eric A Sherer, Merrill J Egorin, et al.
Cancer Chemotherapy and Pharmacology|August 24, 2004
Pharmacokinetic studies of 9-nitrocamptothecin on intermittent and continuous schedules of administration in patients with solid tumorsLaura L Jung, Ramesh K Ramanathan, Merrill J Egorin, et al.
Clinical Pharmacology and Therapeutics|August 14, 2009
Pharmacokinetic study of pegylated liposomal CKD-602 (S-CKD602) in patients with advanced malignanciesW C Zamboni, S Strychor, L Maruca, et al.
American Journal of Clinical Oncology|October 4, 2005
A phase I/II study of trimetrexate and capecitabine in patients with advanced refractory colorectal cancerKhalid Matin, Samuel A Jacobs, Thomas Richards, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 29, 2005
Chemotherapy permits resection of metastatic colorectal cancer: experience from Intergroup N9741T Delaunoit, S R Alberts, D J Sargent, et al.
Cancer Immunology, Immunotherapy : CII|September 17, 2004
Phase I study of a MUC1 vaccine composed of different doses of MUC1 peptide with SB-AS2 adjuvant in resected and locally advanced pancreatic cancerRamesh K Ramanathan, Kenneth M Lee, John McKolanis, et al.
Cancer Chemotherapy and Pharmacology|January 1, 2013
A phase I study of liposomal-encapsulated docetaxel (LE-DT) in patients with advanced solid tumor malignanciesJohn F Deeken, Rebecca Slack, Glen J Weiss, et al.
Cancer|January 20, 2011
Patient willingness to undergo pharmacodynamic and pharmacokinetic tests in early phase oncology trialsRaoul Tibes, Barbara F Piper, Jessica A Smith, et al.
Journal of Pharmaceutical Sciences|January 8, 2011
Validation of 96-well equilibrium dialysis with non-radiolabeled drug for definitive measurement of protein binding and application to clinical development of highly-bound drugsMaciej J Zamek-Gliszczynski, Kenneth J Ruterbories, Rose T Ajamie, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 13, 2008
Five-year data and prognostic factor analysis of oxaliplatin and irinotecan combinations for advanced colorectal cancer: N9741Hanna K Sanoff, Daniel J Sargent, Megan E Campbell, et al.
Pageof 31